Gallium(III)–Salophen as a Dual Inhibitor of Pseudomonas aeruginosa Heme Sensing and Iron Acquisition

• Published in: ACS infectious diseases Vol. 6; no. 8; pp. 2073 - 2085
• Main Authors: Centola, Garrick, Deredge, Daniel J, Hom, Kellie, Ai, Yong, Dent, Alecia T, Xue, Fengtian, Wilks, Angela
• Format: Journal Article
• Language: English
• Published: American Chemical Society 14.08.2020
• Subjects: Pseudomonas aeruginosa; heme sensing; antimicrobials; heme uptake; metallotherapeutics
• ISSN: 2373-8227; 2373-8227
• DOI: 10.1021/acsinfecdis.0c00138

Pseudomonas aeruginosa is an opportunistic bacterium that causes life-threatening infections in immunocompromised patients. In infection, it uses heme as a primary iron source and senses the availability of exogenous heme through the heme assimilation system (Has), an extra cytoplasmic function σ-factor system. A secreted hemophore HasAp scavenges heme and, upon interaction with the outer-membrane receptor HasR, activates a signaling cascade, which in turn creates a positive feedback loop critical for sensing and adaptation within the host. The ability to sense and respond to heme as an iron source contributes to virulence. Consequently, the inhibition of this system will lead to a disruption in iron homeostasis, decreasing virulence. We have identified a salophen scaffold that successfully inhibits the activation of the Has signaling system while simultaneously targeting iron uptake via xenosiderophore receptors. We propose this dual mechanism wherein free Ga3+–salophen reduces growth through uptake and iron mimicry. A dual mechanism targeting extracellular heme signaling and uptake together with Ga3+-induced toxicity following active Ga3+salophen uptake provides a significant therapeutic advantage while reducing the propensity to develop resistance.